These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3519860)
21. Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies. Plagemann PG; Harty JT; Even C Arch Virol; 1992; 123(1-2):89-100. PubMed ID: 1372497 [TBL] [Abstract][Full Text] [Related]
22. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants. Weiland E; Grossmann A; Thiel HJ; Weiland F J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370 [TBL] [Abstract][Full Text] [Related]
23. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. McDonald TL J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738 [TBL] [Abstract][Full Text] [Related]
24. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice. Cafruny WA; Bradley SE; Rowland RR Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362 [TBL] [Abstract][Full Text] [Related]
25. Persistent infection of mice by lactate dehydrogenase-elevating virus: effects of immunosuppression on virus replication and antiviral immune responses. Onyekaba CO; Harty JT; Even C; Hu BG; Plagemann PG Virus Res; 1989 Dec; 14(4):297-315. PubMed ID: 2623944 [TBL] [Abstract][Full Text] [Related]
26. Infection of SCID mice with lactate dehydrogenase-elevating virus stimulates B-cell activation. Bradley DS; Broen JJ; Cafruny WA Viral Immunol; 1991; 4(1):59-70. PubMed ID: 1905935 [TBL] [Abstract][Full Text] [Related]
27. Regulation of maternal-fetal virus transmission in immunologically reconstituted SCID mice infected with lactate dehydrogenase-elevating virus. Broen JB; Bradley DS; Powell KM; Cafruny WA Viral Immunol; 1992; 5(2):133-40. PubMed ID: 1616584 [TBL] [Abstract][Full Text] [Related]
28. Detection of the binding of IgG2a and IgG2b on the surface of macrophages from mice chronically infected with lactic dehydrogenase virus. Hayashi T; Onodera T; Yamamoto H J Comp Pathol; 1992 Jul; 107(1):35-40. PubMed ID: 1430346 [TBL] [Abstract][Full Text] [Related]
29. Immunoglobulins that bind to uncoated ELISA plate surfaces: appearance in mice during infection with lactate-dehydrogenase-elevating virus and in human anti-nuclear antibody-positive sera. Cafruny WA; Heruth DP; Jaqua MJ; Plagemann PG J Med Virol; 1986 Jun; 19(2):175-86. PubMed ID: 3723118 [TBL] [Abstract][Full Text] [Related]
30. The envelope proteins of lactate dehydrogenase-elevating virus and their membrane topography. Faaberg KS; Plagemann PG Virology; 1995 Oct; 212(2):512-25. PubMed ID: 7571421 [TBL] [Abstract][Full Text] [Related]
31. Immune response to lactate dehydrogenase-elevating virus: isolation of infectious virus-immunoglobulin G complexes and quantitation of specific antiviral immunoglobulin G response in wild-type and nude mice. Cafruny WA; Plagemann PG Infect Immun; 1982 Sep; 37(3):1001-6. PubMed ID: 7129626 [TBL] [Abstract][Full Text] [Related]
32. Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms. Markine-Goriaynoff D; Nguyen TD; Bigaignon G; Van Snick J; Coutelier JP Int Immunol; 2001 Sep; 13(9):1185-92. PubMed ID: 11526099 [TBL] [Abstract][Full Text] [Related]
33. Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. van den Broek MF; Spörri R; Even C; Plagemann PG; Hänseler E; Hengartner H; Zinkernagel RM J Immunol; 1997 Aug; 159(4):1585-8. PubMed ID: 9257815 [TBL] [Abstract][Full Text] [Related]
34. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Markine-Goriaynoff D; van der Logt JT; Truyens C; Nguyen TD; Heessen FW; Bigaignon G; Carlier Y; Coutelier JP Int Immunol; 2000 Feb; 12(2):223-30. PubMed ID: 10653858 [TBL] [Abstract][Full Text] [Related]
35. Immune response to lactate dehydrogenase-elevating virus: serologically specific rabbit neutralizing antibody to the virus. Cafruny WA; Plagemann PG Infect Immun; 1982 Sep; 37(3):1007-12. PubMed ID: 7129627 [TBL] [Abstract][Full Text] [Related]
37. Protection of C58 mice from lactate dehydrogenase-elevating virus-induced motor neuron disease by non-neutralizing antiviral antibodies without interference with virus replication. Harty JT; Chan SP; Contag CH; Plagemann PG J Neuroimmunol; 1987 Jun; 15(2):195-206. PubMed ID: 3034974 [TBL] [Abstract][Full Text] [Related]
38. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus. Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715 [TBL] [Abstract][Full Text] [Related]
39. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860 [TBL] [Abstract][Full Text] [Related]
40. Immune responses in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection. Michaelides MC; Simms ES Cell Immunol; 1980 Mar; 50(2):253-60. PubMed ID: 6986993 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]